| |
Bangalore India BIO 2010 ----- Biotech for better tomorrow |
| Date: 02 - 04 June 2010 |
| Venue: Lalit Ashok, Bangalore, India |
| Bangalore India BIO 2010, India's premier biotechnology event organized by the Department of Information Technology, Biotechnology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ Sci-Tech Communications was inaugurated by Mr BS Yeddyurappa, Chief Minister of Karnataka and Mr Katta Subramanya Naidu, Minister for IT & BT, Information, Excise and BWSSB, Government of Karnataka. |
| 'The three-day long event, was held at Hotel Lalit Ashok consisted of Multi-Track Conference, International Trade Show, BioPartnering, CEO Conclave, Bio Excellence Award and a host of other events. The Multi-Track Conference was consist of 25 sessions with over 100 Speakers addressing the sessions. |
| Inaugurating the event, Mr Yeddyurappa said, "Even though Karnataka is a pioneer and commands leadership position in India's biotech sector, the state government is continuously working towards the industry's needs. New Millennium Biotechnology Policy of 2001 has given many incentives and concessions. As a result, the state has accounted for $810 million (26%) of India's biotech market of $3 billion. In the past one year, 11 new Biotech companies have come up in Karnataka, taking the number to 198 out of the 360 in India." |
| Dr Kiran Mazumdar-Shaw gave an account of the 10 years of transformative period, in which Bangalore BIO has evolved to become Bangalore India BIO. She said, "Bangalore has become a global hub for clinical data management and post marketing data management. Now, we have most diversified bioclusters in Karnataka. Of the 380 biotechnology companies of India 198 are in Karnataka and 191 of them are in Bangalore. Having come a long way now is the time to shift from western centric models. India and China can play a lead role in the world in the areas of food security and healthcare." |
| Key topics addressed in Bangalore India BIO 2010 are in the areas of regulatory issues for biopharma industry, bioprocess engineering and biomanufacturing, biocollaborations - between industry, academia and investor; CROs: growth drivers and critical success factors; meeting the challenges and actualizing the potential in clinical trials; biomedical technology: future of diagnostics, medical technology focused for emerging markets; software solutions for biotech, biopharma: drug discovery and the development of innovative R&D; vaccines for emerging medical conditions, neglected diseases and pandemic preparedness; and successfully negotiating the biosimilars landscape. |
| The other dignitaries present during the inauguration included Mr Rob Norris, Minister of Advanced Education, Employment & Labour, Government of Saskatchewan, Canada; Mr SV Ranganath, Chief Secretary, Government of Karnataka; Mr Richard Hyde, British Deputy High Commissioner to Karnataka; Prof. Samir K Brahmachari, DG, CSIR and Secretary, DSIR, Government of India; Mr Ashok Kumar C Manoli, Karnataka Principal Secretary for IT & BT and Science & Technology; Dr Kiran Mazumdar-Shaw, Chairperson, Karnataka's Vision Group on Biotechnology & CMD Biocon; and Mr Aravind Jannu, Director, Directorate of IT & BT, Govt. of Karnataka & Managing Director, KBITS. |
|
